UnknownNot Applicable

Collecting Ducts Carcinoma: in Depth Exploration and Biologically Driven Therapy (CICERONE)

Italy100 participantsStarted 2021-07-08

Plain-language summary

* Collect a large number of samples with certain / suspected diagnosis of collecting duct carcinoma in order to confirm the diagnosis (centralized review) and standardize according to WHO 2016 criteria * Build an extensive tissue bank (DNA and RNA extraction) aimed at defining the molecular taxonomy of the tumor through 1) transcriptomic analysis 2) gene expression profile * Define specific molecular signatures

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years * Signature of consent (for patients enrolled in the prospective part of the study) * Histological diagnosis of renal cell carcinoma of the Bellini collecting duct RCC Exclusion Criteria: \-

What they're measuring

samples to confirm and standardize

Timeframe: 15 month

Trial details

NCT IDNCT05372302

SponsorFondazione IRCCS Istituto Nazionale dei Tumori, Milano

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-10

Contact for this trial

Elena Verzoni, MD

0223904449 elena.verzoni@istitutotumori.mi.it

View on ClinicalTrials.gov More Collecting Duct Carcinoma trials